Immunovant, Inc. Annual Operating Lease, Payments in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Immunovant, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2020 to 2023.
  • Immunovant, Inc. Operating Lease, Payments for the quarter ending March 31, 2021 was $200K.
  • Immunovant, Inc. Operating Lease, Payments for the twelve months ending March 31, 2021 was $900K.
  • Immunovant, Inc. annual Operating Lease, Payments for 2023 was $1.2M, unchanged from 2022.
  • Immunovant, Inc. annual Operating Lease, Payments for 2022 was $1.2M, unchanged from 2021.
  • Immunovant, Inc. annual Operating Lease, Payments for 2021 was $1.2M, a 33.3% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.2M $0 0% Apr 1, 2023 Mar 31, 2024 10-K 2024-05-29
2022 $1.2M $0 0% Apr 1, 2022 Mar 31, 2023 10-K 2024-05-29
2021 $1.2M +$300K +33.3% Apr 1, 2021 Mar 31, 2022 10-K 2022-06-08
2020 $900K Apr 1, 2020 Mar 31, 2021 10-K 2021-06-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.